Position in XERS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$18,509,798
+$3,588,409 QoQ
Shares Held
2,337,096
-9.2% QoQ
Ownership
1.28%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#11
of 238 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 93%
Shared 0%
None 7%
Common Shares in XERS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026MORGAN STANLEY holds $3,507,440,445 across 76 Drug Manufacturers - Specialty & Generic names. XERS ranks #26 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
8,878,849 | $638,034,078 | |
| 2 | HIMS |
Hims & Hers Health, Inc.
|
7,152,498 | $247,977,102 | |
| 3 | VTRS |
Viatris Inc
|
15,128,899 | $240,246,911 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
436,699 | $236,616,614 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
6,968,719 | $236,100,195 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
1,318,607 | $222,238,016 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
7,854,362 | $193,295,842 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
1,726,303 | $191,516,050 |
All Filings in XERS
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,509,798 | 2,337,096 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $14,921,389 | 2,572,654 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $21,256,093 | 2,707,783 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $26,208,364 | 3,219,701 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $17,010,864 | 3,642,584 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $23,542,660 | 4,288,281 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $9,754,776 | 2,877,516 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $6,709,774 | 2,354,308 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $3,622,325 | 1,609,924 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $2,853,013 | 1,290,958 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $2,870,189 | 1,221,358 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $1,187,109 | 638,232 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $868,230 | 331,387 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $251,571 | 154,340 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $157,946 | 118,758 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $183,406 | 117,570 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $195,902 | 127,211 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $359,753 | 140,529 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $3,957,805 | 1,350,787 | Shares | Defined | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||